Skye Bioscience Inc. (SKYE)

SKYE trades at $4.75, 5.0% below the near-term max pain of $5 expiring Oct 17, 2025 (11 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($2.5-$5), reflecting growing call interest at higher strikes. Key magnetic zone at 5 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for SKYE shows an upward trend from 2.5 to 5, suggesting bullish positioning in longer-dated options. The 57% spread signals divergent expectations across timeframes. Most levels above 4.75 could support dips. Strong magnetic level at 5 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.